https://doi.org/10.1186/ 10.1016/s0140-6736(17)33102-180. s12902-022-00980-1. 38. K. Nadolsky, W.T. Garvey, M. Agarwal et al. Endocrine Practice xxx (xxxx) ...
WARNING signs that you might have fatty liver https://t.co/SnG21HkYCB
Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall discussions reflect a balanced interest with references to the article's detailed points, such as liver biopsy as the gold standard and the increasing prevalence linked to obesity and diabetes, showing moderate engagement but an awareness of the disease’s broader health impact.
Most posts acknowledge the importance of NAFLD and its clinical aspects, supporting the article's relevance.
Discussions express moderate interest, especially regarding diagnostic methods and public health impact, but lack deep emotional engagement.
Posts reference specific details like biopsy as the gold standard and implications for health management, indicating some level of detailed engagement.
The conversations highlight the pressing public health challenge posed by NAFLD and confirm its significance in current medical research and practice.
WARNING signs that you might have fatty liver https://t.co/SnG21HkYCB
I am pleased to share our paper from international collaborative authors is now published online: Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. https://t.co/PJjffihYSR
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and efects of weight loss Sjaak Pouwels, et al. https://t.co/bz20eUiUMm Endocr Disord. 2022 Mar 14;22(1):63.BMC
@shunley42 Pubmed is the best place to look. Seems like biopsy is still the gold standard, according to some people. “Histologic evaluation with liver biopsy remains the gold standard to diagnose NAFLD.” https://t.co/Yc4CwdTAea
RT @WahYangMD: I am pleased to share our paper from international collaborative authors is now published online: Non-alcoholic fatty liver…
Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public health. NAFLD is the most common chronic liver dise…https://t.co/uMRGLrXGev https://t.co/QqYgmd02di
This video discusses what fatty liver disease is, its health risks, and the importance of early intervention. It emphasizes lifestyle changes and treatment options to prevent complications like cirrhosis and liver…
This video highlights the early, silent symptoms of fatty liver disease, backed by research. It emphasizes lifestyle, diet, and exercise strategies, and discusses the links to obesity and metabolic disorders, including…
This video explains what fatty liver disease is, its connection to high insulin levels, obesity, and diabetes. It emphasizes the importance of early intervention through lifestyle changes to prevent severe liver…
Fatty liver affects about one in four people worldwide. This video explores the causes, potential severity, and management options for fatty liver disease, emphasizing the importance of lifestyle changes like weight…
Non-alcoholic Fatty Liver Disease affects millions and often remains silent. Early detection through understanding signs and risk factors is crucial for preventing severe liver complications and managing overall health.
Liver disease can cause serious health issues and irreversible damage. This video highlights 10 key symptoms of liver damage, including jaundice and fatigue, emphasizing the importance of early detection and treatment…
Nonalcoholic fatty liver NAFLD is prevalent worldwide and can progress from simple fat buildup to severe liver damage. The disease is often associated with obesity and metabolic disorders, but it can be reversed through…
WARNING signs that you might have fatty liver https://t.co/SnG21HkYCB
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and efects of weight loss Sjaak Pouwels, et al. https://t.co/bz20eUiUMm Endocr Disord. 2022 Mar 14;22(1):63.BMC
Discover key insights on Non-alcoholic Fatty Liver Disease (NAFLD) in a 2022 BMC Endocrine Disorders article. A vital resource for understanding pathophysiology, clinical management, and the impact of weight loss. Stay informed for better health. #NAFLD https://t.co/hXhrVIhBuj
The Basics About Fatty Liver Disease: Causes, Impact, and Solutions #YouTube #PeakHumanLabs #Biohacking https://t.co/rllAQxtNoa https://t.co/uueHLJG4rm
@shunley42 Pubmed is the best place to look. Seems like biopsy is still the gold standard, according to some people. “Histologic evaluation with liver biopsy remains the gold standard to diagnose NAFLD.” https://t.co/Yc4CwdTAea
Given the increasing prevalence of diabetes and obesity worldwide, the deleterious effects of non-alcoholic fatty liver disease (NAFLD) are becoming a growing challenge for public health. NAFLD is the most common chronic liver dise…https://t.co/uMRGLrXGev https://t.co/QqYgmd02di
RT @WahYangMD: I am pleased to share our paper from international collaborative authors is now published online: Non-alcoholic fatty liver…
I am pleased to share our paper from international collaborative authors is now published online: Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss. https://t.co/PJjffihYSR
Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss https://t.co/rCeDWhIFuk
https://doi.org/10.1186/ 10.1016/s0140-6736(17)33102-180. s12902-022-00980-1. 38. K. Nadolsky, W.T. Garvey, M. Agarwal et al. Endocrine Practice xxx (xxxx) ...
2022; doi:10.1186/s12902-022-00980-1. Definition & facts of NAFLD and NASH. National Institute of Diabetes and Digestive and Kidney Diseases. https://www ...
https://doi.org/10.1186/s12902- analysis. J GastroenterolHepatol. 2020; 67: 862- 022-00980-1. PMid:35287643 PMCid:PMC8919523 873 15. Chalasani N, Younossi Z ...
2022; doi:10.1186/s12902-022-00980-1. Definition & facts of NAFLD and NASH. National Institute of Diabetes and Digestive and Kidney Diseases. https://www ...
BMC Endocrine Disorders, 22(1). https://doi.org/10.1186/S12902-022-00980-1. Qayyum, A., Coh, J. S., Kakar, S., Yeh, B. M., Merriman, R. B., & Coakley, F. V. ...
2022; doi:10.1186/s12902-022-00980-1. Definition & facts of NAFLD and NASH. National Institute of Diabetes and Digestive and Kidney Diseases. https://www ...
2022; doi:10.1186/s12902-022-00980-1. Definition & facts of NAFLD and NASH. National Institute of Diabetes and Digestive and Kidney Diseases. https://www ...
https://doi.org/10.1186/s12902-022-00980-1 29. M. F. Abdelmalek, Nonalcoholic fatty liver disease: Another leap forward, Nat. Rev ...
doi:10.1186/s12902-022-00980-1. More On This Topic. The Changing Landscape and Outcome Disparities Among Liver Transplant Waitlist Registrants ...
doi:10.1186/s12902-022-00980-1; Geerts A, Lefere S. Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative ...
2022, 22:63. 10.1186/s12902-022-00980-1 11. Kasper P, Martin A, Lang S, Kütting F, Goeser T, Demir M, Steffen HM: NAFLD and cardiovascular ...
s12902-022-00980-1 - Free download as PDF File ( ... BMC Endocrine Disorders (2022) 22:63. https://doi.org/10.1186/s12902-022-00980-1 ...